{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-008245","form_type":"8-K","ticker":"LGVN","cik":"0001721484","company_name":"Longeveron Inc.","filed_at":"2022-02-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.938307+00:00","generated_at":"2026-06-27T07:06:11.811048+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Longeveron appoints Todd Girolamo to Board of Directors","bullets":["Girolamo appointed as Class II Director effective February 15, 2022; term expires at 2023 annual meeting.","He will serve on the Audit Committee and receive a grant of 5,000 shares of Class A common stock (vesting) plus pro-rated cash retainer.","Girolamo is Chief Legal Officer and SVP of Corporate Development at Caladrius Biosciences (NASDAQ: CLBS).","No arrangements or transactions requiring Item 404(a) disclosure were reported.","Board size unchanged; appointment adds legal, finance, and M&A expertise for Lomecel-B development."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-008245","json":"https://secwatch.observer/filing/0001213900-22-008245.json","markdown":"https://secwatch.observer/filing/0001213900-22-008245.md","text":"https://secwatch.observer/filing/0001213900-22-008245.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1721484/000121390022008245/0001213900-22-008245-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1721484/000121390022008245/ea155885-8k_longeveron.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T07:06:11.811048+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a0c70401cf","claim":"Todd C. Girolamo was appointed as Class II Director at Longeveron Inc..","evidence_excerpt":"On February 15, 2022, Todd C. Girolamo was appointed to the Board of Directors (the “Board”) of Longeveron Inc. (the “Company”), serving as a Class II Director with his term expiring at the Company’s 2023 annual stockholders’ meeting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1721484/000121390022008245/0001213900-22-008245-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}